Your browser doesn't support javascript.
loading
IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma.
Barrio, Santiago; Munawar, Umair; Zhu, Yuan Xiao; Giesen, Nicola; Shi, Chang-Xin; Viá, Matteo Da; Sanchez, Ricardo; Bruins, Laura; Demler, Theresa; Müller, Nicole; Haertle, Larissa; Garitano, Andoni; Steinbrunn, Torsten; Danhof, Sophia; Cuenca, Isabel; Barrio-Garcia, Clara; Braggio, Esteban; Rosenwald, Andreas; Martinez-Lopez, Joaquin; Rasche, Leo; Raab, Marc S; Stewart, A Keith; Einsele, Hermann; Stühmer, Thorsten; Kortüm, K Martin.
Afiliação
  • Barrio S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Munawar U; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.
  • Zhu YX; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Giesen N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Germany.
  • Shi CX; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Viá MD; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Sanchez R; Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain.
  • Bruins L; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Demler T; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.
  • Müller N; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Haertle L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Garitano A; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Steinbrunn T; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Danhof S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Cuenca I; Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain.
  • Barrio-Garcia C; Gene Center, Ludwig-Maximilians University, Munich, Germany.
  • Braggio E; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Martinez-Lopez J; Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC Madrid, Spain.
  • Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Germany.
  • Stewart AK; Department of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
  • Einsele H; Center for Individualized Medicine of the Mayo Clinic, Rochester, MN, USA.
  • Stühmer T; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • Kortüm KM; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.
Haematologica ; 105(5): e237-e241, 2020 05.
Article em En | MEDLINE | ID: mdl-31558666

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha